Article
Cyclooxygenase-2: a novel target for cancer chemotherapy?
Journal of cancer research and clinical oncology - 1 Jul 2001
Dempke W, Rie C, Grothey A, Schmoll H J
Abstract excerpt
Epidemiologic studies have documented a 40-50% reduction in incidence of colorectal cancer in individuals taking nonsteroidal antiinflammatory drugs (NSAIDs). Since NSAIDs are known to inhibit cyclooxygenases (COX-1, COX-2), the basic mechanism of their antitumor effects is conceivably the altered metabolism of arachidonic acid and, subsequently, prostaglandins (PGs). Although COX-2, the inducible isoform, is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
